Pivot Bio Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
304
- Latest Deal Type
-
Later Stage VC
- (Cancelled)
- Investors
-
25
Pivot Bio General Information
Description
Manufacturer of microbial nitrogen fertilizers designed for sustainable crop nutrition. The company's physical products utilize gene-edited microbes that colonize plant roots to convert atmospheric nitrogen into ammonia, providing a continuous and weather-resistant nutrient source that eliminates leaching and enhances uptake for corn, wheat and sorghum growers.
Contact Information
Website
www.pivotbio.comCorporate Office
- Minneapolis, MN
- United States
Corporate Office
- Minneapolis, MN
- United States
Pivot Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC | 01-Sep-2023 | Cancelled | Generating Revenue | |||
| 8. Later Stage VC (Series D) | 19-Jul-2021 | Completed | Generating Revenue | |||
| 7. Debt - General | 19-Mar-2021 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series C) | 30-Apr-2020 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series B) | 13-Sep-2018 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series A) | 22-Mar-2016 | Completed | Generating Revenue | |||
| 3. Seed Round | 30-Oct-2014 | Completed | Startup | |||
| 2. Grant | 01-Oct-2011 | $100K | Completed | Startup | ||
| 1. Accelerator/Incubator | Completed | Startup |
Pivot Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D | ||||||||
| Series C | ||||||||
| Series B | ||||||||
| Series A | 2,495,552 | $0.001000 | $0.51 | $6.41 | $6.41 | 1x | $6.41 | 11.14% |
| Seed | 384,614 | $0.001000 | $0.21 | $2.6 | $2.6 | 1x | $2.6 | 1.72% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Pivot Bio Comparisons
Industry
Financing
Details
Pivot Bio Competitors (13)
One of Pivot Bio’s 13 competitors is Upcycle, a Venture Capital-Backed company based in Fresno, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Upcycle | Venture Capital-Backed | Fresno, CA | ||||
| Ostara | Private Equity-Backed | Saint Louis, MO | ||||
| Nutrient TECH | Private Equity-Backed | Dinuba, CA | ||||
| Actagro | Formerly PE-Backed | Kerman, CA | ||||
| EnviroKure | Venture Capital-Backed | Hicksville, OH |
Pivot Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Pivot Bio Patents
Pivot Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026136197-A1 | Bacteria with modified prophage | Pending | 16-Dec-2024 | ||
| WO-2026128298-A2 | Spray dried formulation and related process for nitrogen fixing bacteria | Pending | 09-Dec-2024 | ||
| WO-2026128298-A3 | Spray dried formulation and related process for nitrogen fixing bacteria | Pending | 09-Dec-2024 | ||
| WO-2025254827-A1 | High throughput real-time in-planta assay of microbial nitrogen fixation activity | Pending | 03-Jun-2024 | ||
| WO-2025155518-A1 | Host cells for enhanced plant growth | Pending | 18-Jan-2024 | C12N15/52 |
Pivot Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Pivot Bio Investors (25)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| AR Audit & Research | Family Office | Minority | ||
| Bayer CropScience United States | VC-Backed Company | Minority | ||
| Continental Grain Company | PE/Buyout | Minority | ||
| G2 Venture Partners | Venture Capital | Minority | ||
| Generation Investment Management | Growth/Expansion | Minority |
Pivot Bio Investments (1)
Pivot Bio’s most recent deal was a Grant with Vive Crop Protection for . The deal was made on 02-May-2017.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Vive Crop Protection | 02-May-2017 | Grant | Agricultural Chemicals |
Pivot Bio FAQs
-
When was Pivot Bio founded?
Pivot Bio was founded in 2010.
-
Where is Pivot Bio headquartered?
Pivot Bio is headquartered in Minneapolis, MN.
-
What is the size of Pivot Bio?
Pivot Bio has 304 total employees.
-
What industry is Pivot Bio in?
Pivot Bio’s primary industry is Agricultural Chemicals.
-
Is Pivot Bio a private or public company?
Pivot Bio is a Private company.
-
What is Pivot Bio’s current revenue?
The current revenue for Pivot Bio is .
-
How much funding has Pivot Bio raised over time?
Pivot Bio has raised $697M.
-
Who are Pivot Bio’s investors?
AR Audit & Research, Bayer CropScience United States, Continental Grain Company, G2 Venture Partners, and Generation Investment Management are 5 of 25 investors who have invested in Pivot Bio.
-
Who are Pivot Bio’s competitors?
Upcycle, Ostara, Nutrient TECH, Actagro, and EnviroKure are some of the 13 competitors of Pivot Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
